Aptose Biosciences Inc Shares Close the Day 12.6% Higher - Daily Wrap
The company saw its shares close the day 12.6% higher than yesterday, with trading volume lower than its 30 day average.
Jan 04, 2022 by Kwhen Finance Editors
Aptose Biosciences Inc (APTO) shares closed today 12.6% higher than it did at the end of yesterday. The stock is currently up 12.6% year-to-date, down 65.3% over the past 12 months, and up 12.6% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.6%.
Trading Activity
- Shares traded as high as $1.55 and as low as $1.30 this week.
- Shares closed 78.9% below its 52-week high and 40.7% above its 52-week low.
- Trading volume this week was 3.6% higher than the 10-day average and 56.7% lower than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Aptose Biosciences Inc | 12.6 | 12.6 | -65.3 | ||
| Dow Jones Industrial Average | 0.6 | 0.6 | 21.6 | -0.6 | 24.0 |
| S&P 500 Index | 0.6 | 0.6 | 29.5 | -0.5 | 31.2 |
| Health Care | -0.9 | -0.9 | 22.3 | -0.8 | 27.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by 115.4%
- The company's stock price performance over the past 12 months lags the peer average by -4010.3%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Aptose Biosciences Inc | APTO | 0 | 12.6 | -65.3 | ||
| Peer Avg | N/A | -7.3 | 5.8 | 1.7 | 11.1 | 39.9 |
| Immunogen, Inc. | IMGN | -21.3 | 0 | 15.0 | ||
| Infinity Pharmaceuticals Inc. | INFI | -4.8 | 6.7 | 13.2 | ||
| Corbus Pharmaceuticals Holdings Inc | CRBP | -1.9 | 8.1 | -46.8 | ||
| Advaxis, Inc. | ADXS | -1.3 | 8.6 | 25.2 | 44.2 | 159.4 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: